> H1N1 Influenza A
        Virus Information
> 
HDMA Announces New
        Executive Committee
        and Board of Directors

> HDMA Testifies at FDA
        on REMS for Certain
        Opioids

> HDMA Opposes Repeal
        of LIFO Inventory
        Accounting Method

> HDMA Announces
        Healthcare Reform
        Principles

> HDMA Announces 2009
        iBusiness Solution
        Award Winnners

 
   
 

print page

 
 

 

 

Prescription Drug Pedigree Requirements

Description
The Prescription Drug Marketing Act (PDMA) was enacted on April 22, 1988 (Public Law 100-293) to respond to problems relating to the safety, efficacy, storage and handling of pharmaceuticals. PDMA established specific requirements for the selling and distribution of prescription drugs. Included in these is a requirement that wholesale distributors of prescription drugs be state licensed according to FDA minimum standards. Nearly ten years after enactment of PDMA, on December 3, 1999, FDA published the final regulation completing the implementation of the Act. This final rule includes provisions dealing with the "authorized distributor of record" and "drug pedigree" elements of PDMA.


Links



Contacts
Dan Bellingham
Director, State Government Affairs
703-885-0236
dbellingham@hdmanet.org

Anita Ducca
Senior Director, Regulatory Affairs
703-885-0240
aducca@hdmanet.org

Liz Gallenagh
Vice President, Government Affairs
703-885-0234
egallenagh@hdmanet.org

Kristen Freitas
Director, Federal Government Affairs
703-885-0232
kfreitas@hdmanet.org

 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D